CTVA.NYSECorteva, INC

Form 4: Corteva Director Pat Ward Reports Acquisition of Shares Through Dividend Reinvestment

Sentiment:

SEC Form 4 Filing


Director Pat Ward reports acquiring 2,990 shares of Corteva, Inc. common stock through dividend reinvestment on April 30, 2025.

Summary

  • On April 30, 2025, Corteva, Inc. Director Pat Ward acquired 2,990 shares of common stock.
  • The acquisition was made through dividend reinvestment at a price of $0 per share.
  • Following the transaction, Ward directly owns 35,757.695 shares of Corteva common stock.
  • Ward also indirectly owns shares held by their spouse.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The director's participation in the dividend reinvestment program signals confidence in the company's future, but it's a routine transaction.

Positives

  • The acquisition of shares through dividend reinvestment demonstrates the director's continued investment in the company.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's continued investment in the company through dividend reinvestment, which is a common practice.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it reflects insider confidence.

Key Dates

DateDescription
04/30/2025Date of transaction: Acquisition of Corteva common stock through dividend reinvestment.
05/02/2025Date of signature on the Form 4 filing.

Keywords

Corteva, Director, Ward, Dividend Reinvestment, Share Acquisition, Form 4, Beneficial Ownership, CTVA

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.